 |
Our Private Placement Loss Attorneys Investigate Investor Losses
HOUSTON, Jan. 19, 2024 /PRNewswire/ -- A slew of brokerage firms allegedly engaged in misconduct or negligence when they promoted iCap securities to clients. Shepherd Smith Edwards and Kantas (investorlawyers.com) is investigating these broker-dealers, including Cambridge Investment Research, over growing concerns of liability for investor losses.
Some 1800 investors were reportedly sold an iCap investment issued by iCap Enterprises, which raised about $245M from them with the help of brokerage firms like Cambridge Investment Research. In return, broker-dealers earned high commissions of up to 10% and other fees from the sales. A number of iCap investors were Chinese nationals in the US who were hoping they would get green cards under the US-EB-5 Immigrant Investor Program.
The iCap investments that were sold:
https://youtu.be/_umXRjpmwMY?si=5KPbFkFS036KFv3f
In 2023, dividend payments were suspended. A few months ago, iCap filed for chapter 11 bankruptcy protection.
The Importance of Hiring Skilled Reg D Private Placement Lawyers
ICap investments, which were primarily in real estate, are Regulation D private placements. This makes them unsuitable for retail customers and inexperienced investors.
Reg D private placements tend to be illiquid and poorly regulated. They are unregistered securities offerings. Our Regulation D private placement attorneys understand the nature of these complex, nontransparent investments and know how to prove that broker-dealer negligence or misconduct was involved.
We are one of the most respected investment loss recovery firms in the United States and more than 90% of our clients have received full or partial financial recovery.
Call (800) 259-9010 today or contact us online if your Cambridge Investment Research broker sold you an iCap investment.
